SEC Filings

8-K
ENVISION HEALTHCARE CORP filed this Form 8-K on 11/13/2017
Entire Document
 


Slide 5

2017 Guidance Comparison (continued) Same Contract assumptions were adjusted from the previous anesthesia rate forecast which were driven by lower-than-expected seasonal anesthesia rate increases from 1H to 2H. The previous forecast assumed trends consistent with the prior year, which have been revised downward in the updated forecast. Of the $43mm variance, ~$5mm is attributable to a shift in exchange composition Lower-than-expected emergency department rate increase Lower-than-expected net volume growth, primarily in emergency department as well as higher labor and other supportive costs For the net new contract revisions, $12mm of the $16mm variance in Adjusted EBITDA is attributable to higher-than-expected new contract signing, resulting in related incremental startup costs higher than originally forecasted Primarily attributable to performance of Evolution Health 1 2 3 1 4 5 2 3 4 5 Note: $22mm of temporary market disruption from natural disasters has been eliminated from 2017 Adjusted EBITDA Guidance.